Overview:
Proscare-5 is a medication primarily used to treat benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland. It belongs to a class of medications known as 5-alpha-reductase inhibitors, specifically targeting the enzyme responsible for converting testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, Proscare-5 helps shrink the prostate gland, alleviating symptoms associated with BPH.
Mechanism of Action:
The active substance in Proscare-5, Finasteride, selectively inhibits the type II isoform of the enzyme 5-alpha-reductase. This enzyme is responsible for the conversion of testosterone to DHT in the prostate gland, skin, and liver. By blocking this enzyme, Proscare-5 effectively lowers DHT levels in the prostate gland, which in turn reduces the size of the prostate and relieves urinary symptoms associated with BPH.
Indications:
Proscare-5 is indicated for the treatment of benign prostatic hyperplasia (BPH) to:
- Reduce the risk of acute urinary retention (AUR) and the need for surgical intervention.
- Improve symptoms of obstructive and irritative voiding (e.g., urinary frequency, urgency, weak stream, hesitancy).
Dosage and Administration:
The recommended dose of Proscare-5 is one 5 mg tablet daily, taken orally with or without food. It is important to take Proscare-5 regularly to experience its full therapeutic benefits. Results may take several months of continuous therapy to become noticeable.
Contraindications:
Proscare-5 is contraindicated in individuals who are:
- Hypersensitive to Finasteride or any component of the formulation.
- Pregnant or may potentially be pregnant due to the risk of harm to a male fetus.
Adverse Reactions:
Common side effects associated with Proscare-5 include:
- Decreased libido
- Erectile dysfunction
- Ejaculation disorder
- Breast tenderness or enlargement
- Skin rash
Less common but potentially serious side effects may include:
- Allergic reactions (e.g., rash, itching, swelling)
- Testicular pain
- Depression
Precautions:
- Proscare-5 should not be handled by women who are pregnant or may become pregnant due to the risk of absorption through the skin.
- Regular monitoring of prostate-specific antigen (PSA) levels is recommended during therapy to detect potential prostate cancer.
Storage:
Store Proscare-5 at room temperature (15-30°C), in a dry place away from light and moisture. Keep out of reach of children and pets.
Conclusion:
Proscare-5, containing Finasteride as its active substance, is a well-established treatment for benign prostatic hyperplasia (BPH), effectively reducing prostate size and improving urinary symptoms associated with the condition. It provides relief from bothersome symptoms and helps reduce the need for surgical intervention in men suffering from BPH
Reviews
There are no reviews yet.